| 1 | weeks | 74,619 |
| 2 | times/month | 10 |
| 3 | p.m | 7 |
| 4 | s-apr | 7 |
| 5 | alpha-ohe1 | 5 |
| 6 | mg/i | 5 |
| 7 | w.g | 5 |
| 8 | ×/wk | 5 |
| 9 | h-ogtt | 4 |
| 10 | mg/kg-randomized | 4 |
| 11 | mw/cm3 | 4 |
| 12 | ounces/day | 4 |
| 13 | subjects/cohort | 4 |
| 14 | alpha-position | 3 |
| 15 | deg/sec | 3 |
| 16 | gmm/m2 | 3 |
| 17 | h-period | 3 |
| 18 | images/cycle | 3 |
| 19 | lawang | 3 |
| 20 | on/3 | 3 |
| 21 | pigs/diet | 3 |
| 22 | weeks-of-age | 3 |
| 23 | weeks/year | 3 |
| 24 | 'before-and-after | 2 |
| 25 | 'non-desaturators | 2 |
| 26 | alpha-hydroxy-dha | 2 |
| 27 | alpha-hydroxypregnenolone | 2 |
| 28 | carcasses/batch | 2 |
| 29 | cigarettes/day-reduction | 2 |
| 30 | double-doses | 2 |
| 31 | groups-control | 2 |
| 32 | gy×1 | 2 |
| 33 | joules/cm2 | 2 |
| 34 | kg·m² | 2 |
| 35 | micro-doses | 2 |
| 36 | ml/min/unit | 2 |
| 37 | trials/target | 2 |
| 38 | week-treatments | 2 |
| 39 | weeks-uad | 2 |
| 40 | 'ethnospecies | 1 |
| 41 | 'fat-soluble | 1 |
| 42 | 'ineffective | 1 |
| 43 | 'meals | 1 |
| 44 | 'online | 1 |
| 45 | 'pill-free | 1 |
| 46 | 'placenta-specific | 1 |
| 47 | 'plausible | 1 |
| 48 | 'treatability | 1 |
| 49 | 'users | 1 |
| 50 | 'water-soluble | 1 |
| 51 | +/-1.01 | 1 |
| 52 | ,686 | 1 |
| 53 | -6a/6a | 1 |
| 54 | -weeks | 1 |
| 55 | 1-6-year-old | 1 |
| 56 | 245±391 | 1 |
| 57 | 500-km | 1 |
| 58 | 654.96 | 1 |
| 59 | 69.3+/-10.3 | 1 |
| 60 | acid-sensitizers | 1 |
| 61 | acutenesses | 1 |
| 62 | aushad | 1 |
| 63 | az- | 1 |
| 64 | bags/day | 1 |
| 65 | bifuranocoumarins | 1 |
| 66 | broilers/batch | 1 |
| 67 | cans/d | 1 |
| 68 | cans/day | 1 |
| 69 | ccops | 1 |
| 70 | chihuahuas | 1 |
| 71 | cities-kunming | 1 |
| 72 | co-morbidites | 1 |
| 73 | completely-spliced | 1 |
| 74 | compounds-pge-3782569 | 1 |
| 75 | cscom | 1 |
| 76 | cvaes | 1 |
| 77 | deletion-type | 1 |
| 78 | dmga | 1 |
| 79 | eeks | 1 |
| 80 | ehr-using | 1 |
| 81 | emt-basics | 1 |
| 82 | fxu | 1 |
| 83 | g/24-hours | 1 |
| 84 | g/bottle | 1 |
| 85 | gamma/ml | 1 |
| 86 | glutamines | 1 |
| 87 | gram-dose | 1 |
| 88 | groups-'partnered | 1 |
| 89 | groups-stage | 1 |
| 90 | gy-boost | 1 |
| 91 | gy×2 | 1 |
| 92 | h/episode | 1 |
| 93 | hongdans | 1 |
| 94 | hour-periods | 1 |
| 95 | hours-post-dose | 1 |
| 96 | hypercalcemics | 1 |
| 97 | hysterectom | 1 |
| 98 | ileal-resected | 1 |
| 99 | images/sec | 1 |
| 100 | inti3-blages-5 | 1 |
| 101 | long-livers | 1 |
| 102 | m.min | 1 |
| 103 | mg.there | 1 |
| 104 | mg•kg-1•d-1 | 1 |
| 105 | mmol/l/day | 1 |
| 106 | months-maturated | 1 |
| 107 | morning-healthy | 1 |
| 108 | ng.ml-1.h-1 | 1 |
| 109 | obstipation/ileus | 1 |
| 110 | oz/week | 1 |
| 111 | p-nonyphenoxypolyethylenglycol | 1 |
| 112 | paired-period | 1 |
| 113 | phenyltheophylline | 1 |
| 114 | plots/thesis | 1 |
| 115 | point-bending | 1 |
| 116 | prm/e | 1 |
| 117 | rams/treatment | 1 |
| 118 | receive-elements | 1 |
| 119 | replicates/group | 1 |
| 120 | saftware | 1 |
| 121 | sbm- | 1 |
| 122 | scans/spectrum | 1 |
| 123 | strokes/tias | 1 |
| 124 | subtreatments | 1 |
| 125 | to16 | 1 |
| 126 | tracheal-aspirates | 1 |
| 127 | uln.patients | 1 |
| 128 | underproductive | 1 |
| 129 | upazillas | 1 |
| 130 | u·kg·h | 1 |
| 131 | weeks-or | 1 |
| 132 | weeks.there | 1 |
| 133 | weeksâ | 1 |
| 134 | wokposts | 1 |
| 135 | year-duration | 1 |
| 136 | zip-ties | 1 |
| 137 | μmol/ml/min | 1 |
| 138 | μw/cm²/nm | 1 |
| 1 | 'before-and-after | 2 |
| 2 | 'ethnospecies | 1 |
| 3 | 'fat-soluble | 1 |
| 4 | 'ineffective | 1 |
| 5 | 'meals | 1 |
| 6 | 'non-desaturators | 2 |
| 7 | 'online | 1 |
| 8 | 'pill-free | 1 |
| 9 | 'placenta-specific | 1 |
| 10 | 'plausible | 1 |
| 11 | 'treatability | 1 |
| 12 | 'users | 1 |
| 13 | 'water-soluble | 1 |
| 14 | +/-1.01 | 1 |
| 15 | ,686 | 1 |
| 16 | -6a/6a | 1 |
| 17 | -weeks | 1 |
| 18 | 1-6-year-old | 1 |
| 19 | 245±391 | 1 |
| 20 | 500-km | 1 |
| 21 | 654.96 | 1 |
| 22 | 69.3+/-10.3 | 1 |
| 23 | acid-sensitizers | 1 |
| 24 | acutenesses | 1 |
| 25 | alpha-hydroxy-dha | 2 |
| 26 | alpha-hydroxypregnenolone | 2 |
| 27 | alpha-ohe1 | 5 |
| 28 | alpha-position | 3 |
| 29 | aushad | 1 |
| 30 | az- | 1 |
| 31 | bags/day | 1 |
| 32 | bifuranocoumarins | 1 |
| 33 | broilers/batch | 1 |
| 34 | cans/d | 1 |
| 35 | cans/day | 1 |
| 36 | carcasses/batch | 2 |
| 37 | ccops | 1 |
| 38 | chihuahuas | 1 |
| 39 | cigarettes/day-reduction | 2 |
| 40 | cities-kunming | 1 |
| 41 | co-morbidites | 1 |
| 42 | completely-spliced | 1 |
| 43 | compounds-pge-3782569 | 1 |
| 44 | cscom | 1 |
| 45 | cvaes | 1 |
| 46 | deg/sec | 3 |
| 47 | deletion-type | 1 |
| 48 | dmga | 1 |
| 49 | double-doses | 2 |
| 50 | eeks | 1 |
| 51 | ehr-using | 1 |
| 52 | emt-basics | 1 |
| 53 | fxu | 1 |
| 54 | g/24-hours | 1 |
| 55 | g/bottle | 1 |
| 56 | gamma/ml | 1 |
| 57 | glutamines | 1 |
| 58 | gmm/m2 | 3 |
| 59 | gram-dose | 1 |
| 60 | groups-'partnered | 1 |
| 61 | groups-control | 2 |
| 62 | groups-stage | 1 |
| 63 | gy-boost | 1 |
| 64 | gy×1 | 2 |
| 65 | gy×2 | 1 |
| 66 | h-ogtt | 4 |
| 67 | h-period | 3 |
| 68 | h/episode | 1 |
| 69 | hongdans | 1 |
| 70 | hour-periods | 1 |
| 71 | hours-post-dose | 1 |
| 72 | hypercalcemics | 1 |
| 73 | hysterectom | 1 |
| 74 | ileal-resected | 1 |
| 75 | images/cycle | 3 |
| 76 | images/sec | 1 |
| 77 | inti3-blages-5 | 1 |
| 78 | joules/cm2 | 2 |
| 79 | kg·m² | 2 |
| 80 | lawang | 3 |
| 81 | long-livers | 1 |
| 82 | m.min | 1 |
| 83 | mg.there | 1 |
| 84 | mg/i | 5 |
| 85 | mg/kg-randomized | 4 |
| 86 | mg•kg-1•d-1 | 1 |
| 87 | micro-doses | 2 |
| 88 | ml/min/unit | 2 |
| 89 | mmol/l/day | 1 |
| 90 | months-maturated | 1 |
| 91 | morning-healthy | 1 |
| 92 | mw/cm3 | 4 |
| 93 | ng.ml-1.h-1 | 1 |
| 94 | obstipation/ileus | 1 |
| 95 | on/3 | 3 |
| 96 | ounces/day | 4 |
| 97 | oz/week | 1 |
| 98 | p-nonyphenoxypolyethylenglycol | 1 |
| 99 | p.m | 7 |
| 100 | paired-period | 1 |
| 101 | phenyltheophylline | 1 |
| 102 | pigs/diet | 3 |
| 103 | plots/thesis | 1 |
| 104 | point-bending | 1 |
| 105 | prm/e | 1 |
| 106 | rams/treatment | 1 |
| 107 | receive-elements | 1 |
| 108 | replicates/group | 1 |
| 109 | s-apr | 7 |
| 110 | saftware | 1 |
| 111 | sbm- | 1 |
| 112 | scans/spectrum | 1 |
| 113 | strokes/tias | 1 |
| 114 | subjects/cohort | 4 |
| 115 | subtreatments | 1 |
| 116 | times/month | 10 |
| 117 | to16 | 1 |
| 118 | tracheal-aspirates | 1 |
| 119 | trials/target | 2 |
| 120 | uln.patients | 1 |
| 121 | underproductive | 1 |
| 122 | upazillas | 1 |
| 123 | u·kg·h | 1 |
| 124 | w.g | 5 |
| 125 | week-treatments | 2 |
| 126 | weeks | 74,619 |
| 127 | weeks-of-age | 3 |
| 128 | weeks-or | 1 |
| 129 | weeks-uad | 2 |
| 130 | weeks.there | 1 |
| 131 | weeks/year | 3 |
| 132 | weeksâ | 1 |
| 133 | wokposts | 1 |
| 134 | year-duration | 1 |
| 135 | zip-ties | 1 |
| 136 | ×/wk | 5 |
| 137 | μmol/ml/min | 1 |
| 138 | μw/cm²/nm | 1 |
| 1 | sbm- | 1 |
| 2 | az- | 1 |
| 3 | mg•kg-1•d-1 | 1 |
| 4 | ng.ml-1.h-1 | 1 |
| 5 | +/-1.01 | 1 |
| 6 | 245±391 | 1 |
| 7 | alpha-ohe1 | 5 |
| 8 | gy×1 | 2 |
| 9 | gmm/m2 | 3 |
| 10 | joules/cm2 | 2 |
| 11 | gy×2 | 1 |
| 12 | 69.3+/-10.3 | 1 |
| 13 | on/3 | 3 |
| 14 | mw/cm3 | 4 |
| 15 | inti3-blages-5 | 1 |
| 16 | to16 | 1 |
| 17 | ,686 | 1 |
| 18 | 654.96 | 1 |
| 19 | compounds-pge-3782569 | 1 |
| 20 | -6a/6a | 1 |
| 21 | dmga | 1 |
| 22 | alpha-hydroxy-dha | 2 |
| 23 | deg/sec | 3 |
| 24 | images/sec | 1 |
| 25 | 'placenta-specific | 1 |
| 26 | cans/d | 1 |
| 27 | aushad | 1 |
| 28 | weeks-uad | 2 |
| 29 | completely-spliced | 1 |
| 30 | groups-'partnered | 1 |
| 31 | months-maturated | 1 |
| 32 | ileal-resected | 1 |
| 33 | mg/kg-randomized | 4 |
| 34 | 1-6-year-old | 1 |
| 35 | paired-period | 1 |
| 36 | h-period | 3 |
| 37 | prm/e | 1 |
| 38 | h/episode | 1 |
| 39 | 'pill-free | 1 |
| 40 | weeks-of-age | 3 |
| 41 | groups-stage | 1 |
| 42 | 'plausible | 1 |
| 43 | 'water-soluble | 1 |
| 44 | 'fat-soluble | 1 |
| 45 | images/cycle | 3 |
| 46 | g/bottle | 1 |
| 47 | phenyltheophylline | 1 |
| 48 | 'online | 1 |
| 49 | alpha-hydroxypregnenolone | 2 |
| 50 | deletion-type | 1 |
| 51 | saftware | 1 |
| 52 | mg.there | 1 |
| 53 | weeks.there | 1 |
| 54 | gram-dose | 1 |
| 55 | hours-post-dose | 1 |
| 56 | 'ineffective | 1 |
| 57 | underproductive | 1 |
| 58 | w.g | 5 |
| 59 | lawang | 3 |
| 60 | point-bending | 1 |
| 61 | cities-kunming | 1 |
| 62 | ehr-using | 1 |
| 63 | carcasses/batch | 2 |
| 64 | broilers/batch | 1 |
| 65 | times/month | 10 |
| 66 | u·kg·h | 1 |
| 67 | mg/i | 5 |
| 68 | oz/week | 1 |
| 69 | ×/wk | 5 |
| 70 | gamma/ml | 1 |
| 71 | p-nonyphenoxypolyethylenglycol | 1 |
| 72 | groups-control | 2 |
| 73 | p.m | 7 |
| 74 | 500-km | 1 |
| 75 | μw/cm²/nm | 1 |
| 76 | cscom | 1 |
| 77 | hysterectom | 1 |
| 78 | scans/spectrum | 1 |
| 79 | m.min | 1 |
| 80 | μmol/ml/min | 1 |
| 81 | year-duration | 1 |
| 82 | cigarettes/day-reduction | 2 |
| 83 | alpha-position | 3 |
| 84 | replicates/group | 1 |
| 85 | weeks/year | 3 |
| 86 | 'before-and-after | 2 |
| 87 | weeks-or | 1 |
| 88 | s-apr | 7 |
| 89 | strokes/tias | 1 |
| 90 | upazillas | 1 |
| 91 | chihuahuas | 1 |
| 92 | hypercalcemics | 1 |
| 93 | emt-basics | 1 |
| 94 | hour-periods | 1 |
| 95 | cvaes | 1 |
| 96 | 'ethnospecies | 1 |
| 97 | zip-ties | 1 |
| 98 | glutamines | 1 |
| 99 | double-doses | 2 |
| 100 | micro-doses | 2 |
| 101 | acutenesses | 1 |
| 102 | tracheal-aspirates | 1 |
| 103 | co-morbidites | 1 |
| 104 | plots/thesis | 1 |
| 105 | eeks | 1 |
| 106 | weeks | 74,619 |
| 107 | -weeks | 1 |
| 108 | 'meals | 1 |
| 109 | hongdans | 1 |
| 110 | bifuranocoumarins | 1 |
| 111 | ccops | 1 |
| 112 | 'users | 1 |
| 113 | long-livers | 1 |
| 114 | acid-sensitizers | 1 |
| 115 | 'non-desaturators | 2 |
| 116 | g/24-hours | 1 |
| 117 | uln.patients | 1 |
| 118 | receive-elements | 1 |
| 119 | week-treatments | 2 |
| 120 | subtreatments | 1 |
| 121 | wokposts | 1 |
| 122 | obstipation/ileus | 1 |
| 123 | trials/target | 2 |
| 124 | pigs/diet | 3 |
| 125 | ml/min/unit | 2 |
| 126 | rams/treatment | 1 |
| 127 | subjects/cohort | 4 |
| 128 | gy-boost | 1 |
| 129 | h-ogtt | 4 |
| 130 | fxu | 1 |
| 131 | mmol/l/day | 1 |
| 132 | ounces/day | 4 |
| 133 | bags/day | 1 |
| 134 | cans/day | 1 |
| 135 | morning-healthy | 1 |
| 136 | 'treatability | 1 |
| 137 | weeksâ | 1 |
| 138 | kg·m² | 2 |